INS and metabolic dysfunction-associated steatotic liver disease: The overweight or obese patients with PCOS had a 5.6-fold and 14.4-fold higher risk of NAFLD when glucose > 4.83 mmol/L and insulin > 111.35 pmol/L, respectively.